Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, AŞ Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eastcoasttroll eastcoasttroll Oct 19, 2011 2:43 PM Flag

    Let's go to the Tape

     

    Peter, can you bring me up to speed on your post?

    They were hired by OPTR to assist the launch of DIFICID. Was part of their incentive OPTR common?

    Cubist earnings due out today at 4PM.

    <<Marketing expenses for the second quarter of 2011 increased $6.3 million compared to the second quarter of 2010 due to Optimer's efforts to establish a commercial infrastructure and prepare for the launch of DIFICID, including the hiring of approximately 100 marketing and sales staff. General and administrative expenses increased $3.8 million compared to the second quarter of 2010, primarily because of higher compensation expense due to additional headcount as well as higher recruitment, consulting, facilities and legal expenses. Research and development expenses increased $4.2 million compared to the second quarter of 2010 due to higher health economics research, pharmacovigilance, medical affairs and publication expenses, as well as higher research and development expenses by OBI associated with the OPT-822 Phase 2/3 trial in breast cancer.>> (from their 2Q earnings report)

    This topic is deleted.